Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 – keeping our finger on the pulse

Author:

Timmerman Philip1,Barfield Matthew2,Portabella Enric Bertran3,Calogero Salvatore4,Cowan Kyra5,Faber Jörg6,Ferrari Luca7,Golob Michaela8,Goodman Jo9,Goodwin Lee10,Gnoth Mark Jean11,Hughes Richard12,Ivanova Tsvetelina13,Jordan Gregor14,Laurén Anna15,Maux Delphine16,McDougall Stuart17,Milushewa Petya13,Nelson Robert18,Pynaert Gwenda19,Sklodowski Kamil7,Sleigh Rebecca12,Struwe Petra20,Verhaeghe Tom21,Wheller Robert12,White Steve22,Zeiser Katja8

Affiliation:

1. European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium

2. Roche Innovation Center Welwyn, Roche Pharma Research & Early Development, Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom

3. Moderna Innovation & Technology Center, Harwell Science & Innovation Campus. Oxford, OX11 0DF, United Kingdom

4. Swiss BioQuant, Biochemical Analysis, Reinach (BL), 4153, Switzerland

5. Merck KGaA, Research & Development, Drug Metabolism & Pharmacokinetics New Biological Entities, Darmstadt, 64293, Germany

6. A&M Labor für Analytik und Metabolismusforschung Service GmbH, Bergheim, 50126, Germany

7. Roche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland

8. Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany

9. AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, United Kingdom

10. Labcorp, Bioanalytical Services, Otley Road, Harrogate, HG3 1PY, United Kingdom

11. Bayer, DMPK, in vivo PK & bioanalytics, Bayer AG, Wuppertal, 42096, Germany

12. Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom

13. Quality & Compliance, Comac Medical, Sofia, 1404, Bulgaria

14. Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalytics & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, 82377, Germany

15. MinervaX, Lund, 223 63, Sweden (employed by at the time of writing of this manuscript: Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Maaløv, DK-2760, Denmark)

16. Syneos Health, Clinical Pharmacology & Bioanalysis, Bioanalysis, Biot, 06410, France

17. Quotient Sciences, Bioanalytical Services, Taylor Drive, Alnwick, Northumberland, NE66 2DH, United Kingdom

18. BioAgilytix Laboratories, Hamburg, 22339, Germany

19. Argenx BV, Bioanalytics, Zwijnaarde, 9052, Belgium

20. Celerion Switzerland AG, Bioanalytical Services, Allmendstrasse, Fehraltorf, 8320, Switzerland

21. J&J Innovative Medicine, BDDS, Beerse, 2340, Belgium

22. GSK, IVIVT-BIB, Gunnells Wood Road, Stevenage, SG1 2NY, United Kingdom

Abstract

The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authorities, the European Bioanalysis Forum organized a workshop on 14 November 2023 in Barcelona, Spain, to discuss unclear and/or ambiguous paragraphs which were identified by the European Bioanalysis Forum community and delegates of the workshop prior to the workshop. This manuscript reports back from the workshop with recommendations and aims at continuing an open scientific discussion within the industry and with regulators in support of a science-driven guideline for the bioanalytical community and in line with the ICH mission – that is, achieve greater harmonization worldwide to ensure that safe, effective and high-quality medicines are developed and registered in the most resource-efficient manner.

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Reference31 articles.

1. Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline

2. EBF Workshop ICH M10 workshop one year into ICH M10. https://e-b-f.eu/ich-m10-workshop-2023-slides/

3. American Association of Pharmaceutical Scientists (AAPS) (2023). https://community.aaps.org/events/event-description?CalendarEventKey=277a20b0-12d7-4001-ab6b-018a2987ca14&CommunityKey=437d6e48-fbcf-4e3f-8824-d820a7b67a47&Home=%2Fcommunities%2Fcommunity-home%2Frecent-community-events&tab=recentcommunityeventsdashboard

4. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). www.nc3rs.org.uk/the-3rs

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3